Dopingiin

Dopingiin is the Mongolian term for the practice of doping in sport, defined as the use or attempted use of substances or methods to enhance athletic performance in violation of competition rules. It encompasses both illegal drug use and the employment of prohibited training or manipulation techniques. Anti-doping authorities describe it as a threat to fair play and athlete health.

Substances and methods commonly involved include anabolic agents (steroids), peptide hormones (growth hormone, insulin-like growth factor), erythropoietin (EPO) and other blood-modifying agents, stimulants, diuretics, beta-2 agonists, and gene doping or blood transfusions. The aim is to boost strength, endurance, recovery, or weight control, often at risks to health and sports integrity.

Governance and testing: The World Anti-Doping Agency (WADA) coordinates global anti-doping standards through the World Anti-Doping Code and the Prohibited List, updated annually. Testing occurs both in and out of competition, with urine and blood samples. Samples may be stored and retested as methods improve. Sanctions can include disqualification, forfeiture of medals, and multi-year bans, imposed by sports federations and national anti-doping organizations.

History and impact: Doping has a long and controversial history in sport. Notable cases and investigations—the Festina affair in cycling (1998), high-profile athletes implicated in the 2000s and 2010s, and the Russian doping program revelations—have shaped policy debates and emphasized the ongoing need for robust testing, transparency, and accountability.

Health and ethics: Doping poses health risks such as cardiovascular problems, liver and kidney damage, hormonal disruption, psychiatric effects, and social consequences. Anti-doping work emphasizes education, rigorous testing, and evidence-based sanctions to protect athletes and maintain the integrity of competition.